Skip to main content
. 2018 May 30;16(2):1659–1665. doi: 10.3892/ol.2018.8836

Figure 3.

Figure 3.

Expression of E-cadherin and patient prognosis in breast cancer with non-metastatic lymph nodes. (A) Non-breast lymph node metastasis group (n=157 cases). (B) Breast cancer lymph node metastasis group (n=293 cases).